EN
登录

FluidForm Bio™欢迎新的执行领导层

FluidForm Bio™ Welcomes New Executive Leadership

CISION 等信源发布 2024-01-04 00:07

可切换为仅中文


Bringing Deep Domain Expertise for Future Growth

为未来的增长带来深入的领域专业知识

WALTHAM, Mass., Jan. 3, 2024 /PRNewswire/ -- FluidForm Bio™ announced that it has named Jonathan Paris as general counsel and head of corporate strategy, Naomi Phaneuf as chief marketing officer, and Alex Lenz as vice president of people & business operations.

马萨诸塞州沃尔瑟姆,2024年1月3日/PRNewswire/--FluidForm Bio™ 宣布任命乔纳森·帕里斯(JonathanParis)为总顾问兼企业战略主管,内奥米·法诺夫(NaomiPhaneuf)为首席营销官,亚历克斯·伦茨(AlexLenz)为人力与商业运营副总裁。

'We are thrilled to introduce the following key executives, each bringing a wealth of experience, strategic vision, and expertise to their respective roles,' said Mike Graffeo, CEO and co-founder at FluidForm Bio™.

FluidForm Bio首席执行官兼联合创始人迈克·格拉福(MikeGraffeo)说:“我们很高兴能介绍以下关键高管,他们都为各自的角色带来了丰富的经验、战略愿景和专业知识。”™.

Paris is a seasoned legal executive and commercial attorney who has counseled domestic and multinational publicly traded and privately held organizations. Most recently, Paris was Senior Vice President, Secretary and General Counsel of Rapid Micro Biosystems, a life sciences technology company, where he led the legal and compliance functions while helping the company IPO.

帕里斯是一位经验丰富的法律执行官和商业律师,曾为国内和跨国上市和私营组织提供咨询。最近,帕里斯担任生命科学技术公司Rapid Micro Biosystems的高级副总裁、秘书长兼总顾问,在帮助该公司IPO的同时,他领导了法律和合规职能部门。

Previously, Paris held numerous leadership positions at Insulet Corporation, Medtronic, and Covidien. Paris received his BA in Economics & Government from Colby College, and an MSF and a JD from Suffolk University..

此前,巴黎曾在Isulet Corporation、Medtronic和Covidien担任过多个领导职位。巴黎获得科尔比学院经济学与政府学学士学位,萨福克大学无国界医生和法学博士学位。。

Phaneuf joins the company with over 19 years of marketing experience and is responsible for leading FluidForm Bio™'s core marketing functions including marketing strategy, brand, communications, digital & social media, and growth. Prior to joining FluidForm Bio™, she served as Senior Vice President of Marketing of SAI360, orchestrating a corporate rebrand and spearheading the marketing strategy.

Phaneuf加入该公司拥有19年以上的营销经验,并负责领导FluidForm Bio™'公司的核心营销职能包括营销战略、品牌、通信、数字和社交媒体以及增长。加入FluidForm Bio之前™, 她曾担任SAI360营销高级副总裁,负责公司品牌重塑,并领导营销战略。

A marketing veteran, Phaneuf has global experience across healthcare, medical technology, cybersecurity, and GRC sectors. Phaneuf holds an MA in Integrated Marketing Communications from Marist College and a BS in Business Administration from Saint Michael's College..

作为一名营销老手,Phaneuf在医疗保健、医疗技术、网络安全和GRC领域拥有全球经验。Phaneuf拥有Marist学院的整合营销传播硕士学位和圣米歇尔学院的工商管理学士学位。。

Recently promoted, Lenz has been a member of the FluidForm Bio™ team since 2019 and is responsible for managing recruitment and people operations in tandem with driving operational excellence. Prior to joining FluidForm Bio™, Lenz served as a principal analyst at Dell EMC leading company-wide technology projects.

伦茨最近晋升为FluidForm Bio的成员™ 团队自2019年成立以来,负责管理招聘和人员运营,同时推动卓越运营。加入FluidForm Bio之前™, Lenz曾担任Dell EMC领先的全公司技术项目的首席分析师。

Previously, Lenz held a variety of senior roles across large corporations and start-ups. Lenz holds a BS in Finance & Accounting Management from Northeastern University..

此前,伦茨曾在大型公司和初创企业担任过各种高级职务。伦茨拥有东北大学财务与会计管理学士学位。。

These new executives join the leadership team to advance FluidForm Bio™'s mission to revolutionize the life sciences industry through innovative tissue therapeutic technologies, breakthrough scientific progress, and an unwavering commitment to improving the quality of life on a global scale.

这些新高管加入领导团队,推进FluidForm Bio™'我们的使命是通过创新的组织治疗技术、突破性的科学进步以及对在全球范围内提高生活质量的坚定承诺,彻底改变生命科学行业。

About FluidForm Bio™ FluidForm Bio™ is creating living human tissue for better treatment of disease. Our patented FRESH™ technology is a revolutionary platform designed to build tissue using cells, proteins, and nothing else. Through partnerships with top life science companies, our technology has been validated to produce the highest quality tissue in a variety of applications.

关于FluidForm Bio™ FluidForm生物™ 正在创造活的人体组织,以更好地治疗疾病。我们的专利新鲜™ 这项技术是一个革命性的平台,旨在利用细胞、蛋白质等构建组织。通过与顶级生命科学公司的合作,我们的技术已被验证可以在各种应用中生产出最高质量的组织。

We deliver human tissue that is indistinguishable from the real thing. Our living tissue will offer therapies to countless patients who deserve better treatment options.   .

我们提供的人体组织与真实组织没有区别。我们的活组织将为无数值得更好治疗选择的患者提供治疗。 。

FluidForm Bio™ was founded in 2018 on the belief that the world needs transformational technologies led by creative and passionate experts that help people lead better lives. Headquartered in Waltham, MA, learn more at fluidformbio.com or connect on Twitter and LinkedIn.

FluidForm生物™ 公司成立于2018年,基于这样一种信念,即世界需要由富有创造力和激情的专家领导的变革性技术,以帮助人们过上更好的生活。总部位于马萨诸塞州沃尔瑟姆,可通过fluidformbio.com了解更多信息,或通过Twitter和LinkedIn连接。

SOURCE FluidForm Bio

源FluidForm Bio